Risk for Kidney Complications Increased After Heart Failure Hospitalization
By Elana Gotkine HealthDay Reporter
WEDNESDAY, June 5, 2024 -- Older adults with heart failure have considerable risk for kidney complications, with 6 percent progressing to dialysis at one year after hospitalization, according to a study published online May 29 in JAMA Cardiology.
John W. Ostrominski, M.D., from Brigham and Women's Hospital and Harvard Medical School in Boston, and colleagues examined rates of incident dialysis and acute kidney injury (AKI) among Medicare beneficiaries after heart failure hospitalization in a retrospective cohort study involving 85,298 adults aged 65 years or older.
The researchers found that 6, 7, and 7 percent of patients had progressed to dialysis, had progressed to dialysis or end-stage kidney disease, and had been readmitted for AKI, respectively, by one year after heart failure hospitalization. There was a steep increase seen in incident dialysis with lower discharge estimated glomerular filtration rate (eGFR) category: Individuals with an eGFR of 45 to <60 and of <30 versus ≥60 mL/min/1.73 m2 had higher rates of dialysis readmission (adjusted hazard ratios, 2.16 and 28.46, respectively). Higher rates of readmission for dialysis, dialysis or end-stage kidney disease, and AKI were observed for lower discharge eGFR (per 10 mL/min/1.73 m2 decrease; adjusted hazard ratios, 2.23, 2.34, and 1.25, respectively), with similar findings seen for all-cause mortality, all-cause readmission, and heart failure readmission.
"These findings emphasize the need for health care delivery approaches prioritizing both cardiovascular and kidney health in this high-risk population," the authors write.
Several authors disclosed ties to the biopharmaceutical industry; the Get With The Guidelines-Heart Failure program is partially sponsored by pharmaceutical companies. This analysis was supported by AstraZeneca.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2024
Read this next
ACEi, ARB Use Linked to Lower Risk for Kidney Failure With Replacement Therapy
MONDAY, July 8, 2024 -- For individuals with advanced chronic kidney disease (CKD), angiotensin-converting enzyme inhibitor (ACEi) or angiotensin-receptor blocker (ARB) treatment...
Few With Type 2 Diabetes Receive Guideline-Recommended CKD Screening
MONDAY, July 1, 2024 -- Fewer than one-quarter of patients with type 2 diabetes (T2D) receive recommended chronic kidney disease (CKD) screening, according to a study published...
ADA: Semaglutide Similarly Effective in Men, Women With Obesity-Linked Heart Failure
WEDNESDAY, June 26, 2024 -- For patients with obesity-related heart failure with preserved ejection fraction (HFpEF), semaglutide reduces body weight to a greater extent in women...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.